Dear EditorDNA repair plays a major role in maintaining genomic integrity such that deficiency, as well as an excess of DNA repair, has a significant impact. For example, the absence of DNA polymerase β(pol β) expression in mice results in embryonic lethality, while over-expression of pol β causes cataracts [1,2]. Alkylated DNA bases in higher eukaryotes are repaired predominantly by the base excision repair (BER) pathway. During "single-nucleotide" BER, an alkylated base is removed by the damage specific glycosylase, 3-methyladenine DNA glycosylase, and the resulting abasic site is cleaved by apurinic/apyrimidinic endonuclease. This results in a nick with a 5' dRP group that can be removed by the dRP lyase activity of pol β; the same polymerase then fills the single-nucleotide gap. Finally, a DNA ligase seals the nick completing repair (reviewed in [3]).Mouse embryonic fibroblasts (MEFs) deficient in pol β demonstrate increased sensitivity to alkylating agents such as methyl methanesulfonate (MMS) [4]. Hypersensitivity is moderate, and cellular extracts from pol β null cells have some residual BER activity, suggesting that other polymerases could participate in BER. Reversal of the MMS hypersensitivity requires the dRP lyase activity of pol β [5]. DNA polymerase λ(pol λ) also has dRP lyase activity and can function as a back up BER enzyme in pol β null cells [6,7].Another DNA polymerase carrying dRP lyase activity is DNA polymerase ι(pol ι) [7,8]. This polymerase is a member of the Y-family of DNA polymerases and was identified due to its homology with DNA polymerase η(pol η) [9]. Based on in vitro biochemical data and on the structure of the enzyme, it has been proposed that pol ι participates in DNA translesion synthesis during bypass of a damaged template [10,11]. Gene expression at the mRNA level is modest in most tissues, with strongest expression in testis and ovarian cells [9]. The data on the biological roles of this enzyme are contradictory. Pol ι is expressed at a high level in some human cancer cells and also is associated with increased frequency of mutagenesis in certain cell types; lowering the expression of this enzyme decreased mutation frequency [12]. Deletion of the pol ι gene in human Burkitt's lymphoma cells reduced inducible somatic hypermutation (SHM), and this process could be restored by expression of pol ι [13,14]. At the same time, a *Corresponding author. Tel.: 919-541-3267; Fax: 919-541-3592, E-mail address: wilson5@niehs.nih.gov (S.H. Wilson). Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public AccessAuthor Manuscript DNA Repair (Amst...